Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4524962 | 5695244 | I | 4524962-7 | 20030630 | 20030703 | 20041117 | PER | C2003-1656.01 | MYLAN PHARMACEUTICALS INC. | 44 | YR | M | N | 20031002 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4524962 | 1005483615 | PS | CLOZAPINE | 1 | ORAL | 100MG Q AM, 100MG Q HS, ORAL | Y | D | 75417 | ||
| 4524962 | 1005491392 | C | ALBUTEROL SULFATE | 1 | |||||||
| 4524962 | 1005491393 | C | DIVALPROEX SODIUM | 1 | |||||||
| 4524962 | 1005491395 | C | DOCUSATE SODIUM | 2 | |||||||
| 4524962 | 1005491396 | C | LEVOTHYROXINE SODIUM | 1 | |||||||
| 4524962 | 1005491397 | C | OLANZAPINE | 1 | |||||||
| 4524962 | 1005491398 | C | TOPIRMATE | 1 | |||||||
| 4524962 | 1005491399 | C | VALDECOXIB | 1 | |||||||
| 4524962 | 1005491400 | C | CLONAZEPAM | 1 | |||||||
| 4524962 | 1005491401 | C | SENNA | 2 | |||||||
| 4524962 | 1005491402 | C | DESMOPRESSIN ACETATE | 1 | |||||||
| 4524962 | 1005491403 | C | LORAZEPAM | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4524962 | 1005483615 | SCHIZOAFFECTIVE DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4524962 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4524962 | NEUTROPHIL COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4524962 | HP |
| 4524962 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4524962 | 1005483615 | 20030619 | 20030702 |